To identify a biomarker that determines the sensitivity to the combination tested in this study, the genetic variations in lung cancer cell lines were considered and differences in TP53 gene features were identified between the cells as follows: H460 and A549 (p53 wild type), H1703 (p53 mutant), and H358 (p53 null) cell lines. Here, TP53 is linked to lung cancer.